sodium phosphate (NaH2PO4)

From Aaushi
Jump to navigation Jump to search

Indications

Contraindications

Dosage

Injection:

Adverse effects

* phosphate toxicity can result in hypocalcemic tetany[3] & chronic renal failure[4][6][7] risk of acute phosphate nephropathy is low[5]

More general terms

More specific terms

Additional terms

Component of

References

  1. Drug Information & Medication Formulary, Veterans Affairs, Central California Health Care System, 1st ed., Ravnan et al eds, 1998
  2. Kaiser Permanente Northern California Regional Drug Formulary, 1998
  3. Jump up to: 3.0 3.1 Medications Can Cause Seizures Prescriber's Letter 10(3):16 2003 Detail-Document#: http://prescribersletter.com/(5bhgn1a4ni4cyp2tvybwfh55)/pl/ArticleDD.aspx?li=1&st=1&cs=&s=PRL&pt=3&fpt=25&dd=190320&pb=PRL (subscription needed) http://www.prescribersletter.com
  4. Jump up to: 4.0 4.1 Markowitz GS, Stokes MB, Radhakrishnan J, D'Agati VD. Acute phosphate nephropathy following oral sodium phosphate bowel purgative: an underrecognized cause of chronic renal failure. J Am Soc Nephrol. 2005 Nov;16(11):3389-96. Epub 2005 Sep 28. PMID: https://www.ncbi.nlm.nih.gov/pubmed/16192415
  5. Jump up to: 5.0 5.1 Russman S et al, Risk of impaired renal function after colonoscopy: A cohort study of patients receiving either oral sodium phosphoate or polyethylene glycol. Am J Gastroenterol 2007, 102:2655 PMID: https://www.ncbi.nlm.nih.gov/pubmed/17970832
  6. Jump up to: 6.0 6.1 6.2 Prescriber's Letter 15(5): 2008 Kidney Damage from Sodium Phosphate Bowel Preps Detail-Document#: http://prescribersletter.com/(5bhgn1a4ni4cyp2tvybwfh55)/pl/ArticleDD.aspx?li=1&st=1&cs=&s=PRL&pt=3&fpt=25&dd=240505&pb=PRL (subscription needed) http://www.prescribersletter.com
  7. Jump up to: 7.0 7.1 FDA MedWatch http://www.fda.gov/medwatch/safety/2008/safety08.htm#OSP
  8. Jump up to: 8.0 8.1 Prescriber's Letter 16(1): 2009 Oral Sodium Phosphate Products for Bowel Cleansing: More Safety Concerns Detail-Document#: http://prescribersletter.com/(5bhgn1a4ni4cyp2tvybwfh55)/pl/ArticleDD.aspx?li=1&st=1&cs=&s=PRL&pt=3&fpt=25&dd=250114&pb=PRL (subscription needed) http://www.prescribersletter.com
  9. Jump up to: 9.0 9.1 9.2 Deprecated Reference
  10. Jump up to: 10.0 10.1 FDA MedWatch. Jan 8, 2014 Sodium Phosphate Over-the-Counter Products: Drug Safety Communication - Possible Harm From Exceeding Recommended Dose. http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm380833.htm

Database